Infection and pulmonary vascular diseases consortium: United against a global health challenge DOI Creative Commons
Suellen Darc Oliveira, Sharilyn Almodóvar, Ghazwan Butrous

et al.

Pulmonary Circulation, Journal Year: 2024, Volume and Issue: 14(4)

Published: Oct. 1, 2024

Abstract Leveraging the potential of virtual platforms in post‐COVID‐19 era, Infection and Pulmonary Vascular Diseases Consortium (iPVDc), with support Research Institute (PVRI), launched a globally accessible educational program to highlight top‐notch research on inflammation infectious diseases affecting lung vasculature. This innovative series has already successfully brought together distinguished investigators across five continents – Asia, Europe, South North America, Africa. Moreover, these open global forums have contributed comprehensive understanding complex interplay among immunology, inflammation, infection, cardiopulmonary health, especially concerning pulmonary hypertension related disorders. These enlightening discussions not only heightened awareness about impact various pathogenic microorganisms, including fungi, parasites, viruses, onset development vascular but also cast spotlight co‐infections neglected illnesses like schistosomiasis ‐ disease that continues impose heavy socioeconomic burden numerous regions worldwide. Thus, overall goal this review article is present most recent breakthroughs from PVDs as well bring light scientific insights 2023 iPVDc/PVRI symposium series, shaping our crucial health issues more than ever interconnected world.

Language: Английский

Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and Adolescents DOI Open Access

Suchitra Rao,

Grace M. Lee, Hanieh Razzaghi

et al.

JAMA Pediatrics, Journal Year: 2022, Volume and Issue: 176(10), P. 1000 - 1000

Published: Aug. 23, 2022

The postacute sequelae of SARS-CoV-2 infection (PASC) has emerged as a long-term complication in adults, but current understanding the clinical presentation PASC children is limited.To identify diagnosed symptoms, health conditions, and medications associated with children.This retrospective cohort study used electronic records from 9 US children's hospitals for individuals younger than 21 years who underwent antigen or reverse transcriptase-polymerase chain reaction (RT-PCR) testing between March 1, 2020, October 31, 2021, had at least 1 encounter 3 before testing.SARS-CoV-2 positivity by viral test (antigen RT-PCR).Syndromic (symptoms), systemic (conditions), medication features were identified 28 to 179 days following initial date. Adjusted hazard ratios (aHRs) obtained 151 clinically predicted contrasting test-positive groups test-negative using proportional hazards models, adjusting site, age, sex, location, race ethnicity, time period entrance. incidence proportion any syndromic, systemic, feature was estimated 2 obtain burden estimate.Among 659 286 sample, 348 091 (52.8%) male, mean (SD) age 8.1 (5.7) years. A total 59 893 (9.1%) tested positive SARS-CoV-2, 599 393 (90.9%) negative. Most outpatient facility settings (322 813 [50.3%]) office (162 138 [24.6%]). most common loss taste smell (aHR, 1.96; 95% CI, 1.16-3.32), myocarditis 3.10; 1.94-4.96), cough cold preparations 1.52; 1.18-1.96), respectively. 41.9% (95% 41.4-42.4) among vs 38.2% 38.1-38.4) children, an difference 3.7% 3.2-4.2). higher strength association those cared intensive care unit during acute illness phase, 5 years, complex chronic conditions.In this large-scale, exploratory study, pediatric that presented systems low. Myocarditis commonly PASC-associated condition. Acute severity, young comorbid disease increased risk PASC.

Language: Английский

Citations

121

Damage to endothelial barriers and its contribution to long COVID DOI Open Access
Xiaoming Wu, Mengqi Xiang, Haijiao Jing

et al.

Angiogenesis, Journal Year: 2023, Volume and Issue: 27(1), P. 5 - 22

Published: April 27, 2023

Language: Английский

Citations

48

Distinct type 1 immune networks underlie the severity of restrictive lung disease after COVID-19 DOI
Glenda Canderan, Lyndsey M. Muehling, Alexandra Kadl

et al.

Nature Immunology, Journal Year: 2025, Volume and Issue: unknown

Published: March 26, 2025

Language: Английский

Citations

2

Unsupervised discovery of tissue architecture in multiplexed imaging DOI Open Access
Junbum Kim, Samir Rustam, Juan Miguel Mosquera

et al.

Nature Methods, Journal Year: 2022, Volume and Issue: 19(12), P. 1653 - 1661

Published: Oct. 31, 2022

Language: Английский

Citations

61

Chest CT Findings in Hospitalized Patients with SARS-CoV-2: Delta versus Omicron Variants DOI
Soon Ho Yoon, Jong Hyuk Lee, Baek-Nam Kim

et al.

Radiology, Journal Year: 2022, Volume and Issue: 306(1), P. 252 - 260

Published: June 28, 2022

Background CT manifestations of SARS-CoV-2 may differ among variants. Purpose To compare the chest findings between Delta and Omicron Materials Methods This retrospective study collected consecutive baseline images hospitalized patients with from a secondary referral hospital when variants were predominant. Two radiologists categorized according to RSNA classification system for COVID-19 visually graded pneumonia extent. Pneumonia, pleural effusion, intrapulmonary vessels segmented quantified on using priori–developed neural networks, followed by reader confirmation. Multivariable logistic linear regression analyses performed examine associations category, distribution, severity, peripheral vascularity. Results In total, 88 variant (mean age, 67 years ± 15 [SD]; 46 men) 62 19; 51 included. was associated less frequent, typical bilateral ground-glass opacity (32% [28 88] vs 57% [50 88], P = .001), more frequent peribronchovascular predilection (38% [25 66] 7% [five 71], < lower visual extent (5.4 6.0 7.7 6.6, .02), similar volume (5% 1 11, .14), higher proportion cross-sectional area smaller than 5 mm2 relative total pulmonary blood (BV5%; 48% 11 44% 8; .004). adjusted analyses, nontypical appearance (odds ratio, 0.34; .006), 9.2; BV5% (β 3.8; .01) but (P .17) .67) variant. Conclusion At CT, SARS-COV-2 showed vascular involvement did in disease severity. © RSNA, 2022 Online supplemental material is available this article.

Language: Английский

Citations

55

Long-term mortality following SARS-CoV-2 infection: A national cohort study from Estonia DOI Creative Commons
Anneli Uusküla, Tuuli Jürgenson,

Heti Pisarev

et al.

The Lancet Regional Health - Europe, Journal Year: 2022, Volume and Issue: 18, P. 100394 - 100394

Published: April 29, 2022

The objective of this study was to describe 12-month mortality following SARS-CoV-2 infection compared with a reference population no history SARS-CoV-2.Nationwide cohort using electronic health care data on RNA positive cases (n= 66,287) and group subjects (n=254,969) linkage testing death records.People infected SARS-COV-2 had more than three times the risk dying over year those who remained uninfected (aHR 3·1, 95%CI 2·9-3·3). Short-term (up 5 weeks post-infection) significantly higher among COVID-19 (1623·0/10 000) in (118/10 000). For aged 60 years or older, increased persisted until end first after infection, related for cardiovascular 2·1, 1·8-2·3), cancer 1·5, 1·2-1·9), respiratory system diseases 1·9, 1·2-3·0), other causes 1·8, 1·4-2·2).Increased from is not limited acute illness: carries substantially 12 months. This excess mainly occurs older people driven by broad array death.Research carried out support Estonian Research Council (grants PRG1197, PRG198), European Regional Development Fund (RITA 1/02-120) Social via IT Academy program.

Language: Английский

Citations

53

The vascular perspective on acute and chronic lung disease DOI Creative Commons
Izabela Borek, Anna Birnhuber,

Norbert F. Voelkel

et al.

Journal of Clinical Investigation, Journal Year: 2023, Volume and Issue: 133(16)

Published: Aug. 14, 2023

The pulmonary vasculature has been frequently overlooked in acute and chronic lung diseases, such as respiratory distress syndrome (ARDS), fibrosis (PF), obstructive disease (COPD). primary emphasis the management of these parenchymal disorders largely revolved around injury aberrant repair epithelial cells. However, there is increasing evidence that vascular endothelium plays an active role development diseases. endothelial cell network capillary bed arterial venous vessels provides a metabolically highly barrier controls migration immune cells, regulates tone permeability, participates remodeling processes. Phenotypically functionally altered remodeled vessels, can be found although to different degrees, likely because disease-specific mechanisms. Since associated with hypertension, which worsens patient outcomes survival, it crucial understand underlying alterations. In this Review, we describe current knowledge regarding progression ARDS, PF, COPD; also outline future research directions hope facilitating mechanism-based therapies.

Language: Английский

Citations

36

SARS-CoV-2 spike protein receptor-binding domain perturbates intracellular calcium homeostasis and impairs pulmonary vascular endothelial cells DOI Creative Commons
Kai Yang, Shiyun Liu, Yan Han

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2023, Volume and Issue: 8(1)

Published: July 14, 2023

Abstract Exposure to the spike protein or receptor-binding domain (S-RBD) of SARS-CoV-2 significantly influences endothelial cells and induces pulmonary vascular endotheliopathy. In this study, angiotensin-converting enzyme 2 humanized inbred (hACE2 Tg) mice cultured were used investigate how protein/S-RBD impacts endothelium. Results show that S-RBD leads acute-to-prolonged induction intracellular free calcium concentration ([Ca 2+ ] i ) via acute activation TRPV4, prolonged upregulation mechanosensitive channel Piezo1 store-operated (SOCC) key component Orai1 in human arterial (PAECs). mechanism, interacts with ACE2 induce formation clusters involving Orai1, TRPC1, facilitate SOCC, lead elevated apoptosis. These effects are blocked by Kobophenol A, which inhibits binding between ACE2, chelator, BAPTA-AM. Blockade SOCC GsMTx4 effectively protects S-RBD-induced microvascular damage hACE2 Tg normalizing [Ca . Comparing prototypic strain, Omicron variants (BA.5.2 XBB) less severe cell Transcriptomic analysis indicates confers more than Delta Lambda S-RBD. summary, study provides compelling evidence could persistent triggering through Orai1. Targeted inhibition ACE2-Piezo1/SOCC-[Ca axis proves a powerful strategy treat diseases.

Language: Английский

Citations

30

Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review DOI Open Access
Marianne Riou, F Coste, Alain Meyer

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(9), P. 4941 - 4941

Published: April 30, 2024

Despite the end of pandemic, coronavirus disease 2019 (COVID-19) remains a major public health concern. The first waves virus led to better understanding its pathogenesis, highlighting fact that there is specific pulmonary vascular disorder. Indeed, COVID-19 may predispose patients thrombotic in both venous and arterial circulation, many cases severe acute embolism have been reported. demonstrated presence respiratory syndrome 2 (SARS-CoV-2) within endothelial cells suggests direct viral effects, addition indirect effects perivascular inflammation coagulopathy, contribute vasculopathy COVID-19. In this review, we discuss pathological mechanisms leading damage during infection, which appear be mainly related thromboembolic events, an impaired coagulation cascade, micro- macrovascular thrombosis, endotheliitis hypoxic vasoconstriction. As develop post-COVID symptoms, including dyspnea, also hypothesis hypertension as sequela involved pathophysiology long COVID.

Language: Английский

Citations

9

Beyond the virus: ecotoxicological and reproductive impacts of SARS-CoV-2 lysate protein in C57Bl/6j female mice DOI
Bárbara Beatriz da Silva Nunes,

Juliana dos Santos Mendonça,

Letícia Paiva de Matos

et al.

Environmental Science and Pollution Research, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 2, 2025

Language: Английский

Citations

1